tetraethylammonium has been researched along with Cognitive Decline in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yan, W | 1 |
| Zhang, M | 1 |
| Yu, Y | 1 |
| Yi, X | 1 |
| Guo, T | 1 |
| Hu, H | 1 |
| Sun, Q | 1 |
| Chen, M | 1 |
| Xiong, H | 1 |
| Chen, L | 1 |
1 other study available for tetraethylammonium and Cognitive Decline
| Article | Year |
|---|---|
Blockade of voltage-gated potassium channels ameliorates diabetes-associated cognitive dysfunction in vivo and in vitro.
Topics: 4-Aminopyridine; Animals; Cell Survival; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Mic | 2019 |